Edition:
United Kingdom

Neuca SA (NEUP.WA)

NEUP.WA on Warsaw Stock Exchange

254.50PLN
11:48am GMT
Change (% chg)

-0.50zł (-0.20%)
Prev Close
255.00zł
Open
256.00zł
Day's High
256.00zł
Day's Low
252.50zł
Volume
138
Avg. Vol
1,001
52-wk High
316.50zł
52-wk Low
221.00zł

Chart for

About

Neuca SA is a Poland-based company engaged in the healthcare sector. The Company’s main activities comprise the wholesale of pharmaceuticals; running its own pharmacies under the brand name Synoptis Pharma; provision of advertising, marketing and information technology (IT) services to healthcare market, production of pharmaceut... (more)

Overall

Beta: 0.16
Market Cap(Mil.): zł1,264.09
Shares Outstanding(Mil.): 4.68
Dividend: 5.75
Yield (%): 2.13

Financials

  NEUP.WA Industry Sector
P/E (TTM): 14.02 21.46 40.43
EPS (TTM): 19.28 -- --
ROI: 15.06 11.84 60.70
ROE: 17.17 13.75 72.00

BRIEF-Neuca Receives Notice From Tax Office Regarding 2012 Tax Payment

* SAYS IT RECEIVED DECISION OF HEAD OF CUSTOMS AND TAX OFFICE IN TORUN DETERMINING THE TAX LIABILITY IN INCOME TAX FORM 2012 IN THE AMOUNT OF 7.7 MLN ZLOTYS PLUS DUE INTEREST

20 Nov 2018

BRIEF-Neuca Offers To Buy Back 150,000 Of Own Shares

* OFFERS TO BUY BACK NO MORE THAN 150,000 OF CO'S SHARES REPRESENTING 3.24 PCT OF ITS SHARE CAPITAL FOR 235 ZLOTYS/SHARE

13 Nov 2018

BRIEF-Neuca Q3 Net Profit Up At 24.1 Mln Zlotys

* REPORTS Q3 NET PROFIT OF 24.1 MLN ZLOTYS VS 21.7 MLN ZLOTYS YEAR AGO

12 Nov 2018

BRIEF-Neuca Q2 Net Profit Rises To 18.5 Mln Zlotys

Aug 29 NEUCA SA: * Q2 NET PROFIT 18.5 MLN ZLOTYS VS 11.8 MLN ZLOTYS YEAR AGO * Q2 REVENUE 1.78 BLN ZLOTYS VS 1.78 BLN ZLOTYS YEAR AGO * Q2 OPER PROFIT 24.8 MLN ZLOTYS VS 16.1 MLN ZLOTYS YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

29 Aug 2018

Earnings vs. Estimates